Company Filing History:
Years Active: 2025
Title: Innovations in Autoimmune Disease Evaluation by Jing Yao Leong
Introduction
Jing Yao Leong is a notable inventor based in Singapore, recognized for her contributions to the field of autoimmune disease evaluation. With a focus on clinical outcomes, her work aims to enhance the understanding and management of autoimmune conditions.
Latest Patents
Jing Yao Leong holds a patent titled "Methods and kits for evaluating clinical outcomes of autoimmune disease." This patent specifically addresses the evaluation of disease flare in conditions such as juvenile idiopathic arthritis (JIA). The invention involves comparing biomarkers such as CD45RA, TNF-alpha, and CXCR5 from the CD3CD4 T cell population. A key aspect of the patent is the determination of the ratio of memory T cells to naïve T cells, where an increase in this ratio indicates a disease flare state. Additionally, the patent explores the enrichment of specific T cell subsets and their implications for predicting flare states in autoimmune diseases.
Career Highlights
Jing Yao Leong is affiliated with Singapore Health Services Pte Ltd, where she applies her expertise in clinical research and innovation. Her work has significantly contributed to the understanding of autoimmune diseases and the development of effective evaluation methods.
Collaborations
Jing collaborates with Salvatore Albani, a fellow researcher in the field. Their partnership focuses on advancing the understanding of autoimmune diseases and improving clinical outcomes for patients.
Conclusion
Jing Yao Leong's innovative work in evaluating autoimmune diseases through her patented methods and kits represents a significant advancement in the field. Her contributions are vital for improving patient care and understanding disease mechanisms.